Wolbrom, Poland

Gniewomir Latacz

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.6

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Gniewomir Latacz: Innovator in Neurological Treatments**

Introduction

Gniewomir Latacz, based in Wolbrom, Poland, is a distinguished inventor known for his contributions to the field of pharmacology, particularly focusing on treatments for neurological diseases and psychiatric disorders. With a total of two patents to his name, Latacz is making significant strides in improving therapeutic options available to patients suffering from various ailments.

Latest Patents

Latacz's latest patents encompass innovative compounds that show promise in treating neurological diseases. One notable invention is the "Modified amino acid derivatives for the treatment of neurological diseases and selected psychiatric disorders." This patent details the compounds 2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2-oxopyrrolidin-1-yl)propanamide derivatives, which exhibit broad-spectrum protective activity in animal models suffering from epileptic seizures, pain, depression, and anxiety. Notably, these derivatives are distinguished by their lack of undesirable sedative effects and their neuroprotective properties in both in vitro and in vivo studies.

Another significant patent involves "(2,5-dioxopyrrolidin-1-yl)(phenyl)-acetamide derivatives and their use in the treatment of neurological diseases." This invention includes the compound of general formula (I) or its pharmaceutically acceptable salts. The derivatives described under this patent are proposed for use as active ingredients in pharmaceutical compositions targeting conditions such as epileptic seizures, neuropathic pain, or migraine.

Career Highlights

Gniewomir Latacz has worked at prominent institutions that have facilitated his research endeavors. Notable among these are Jagiellonian University and the Medical University of Warsaw. His academic background and research facilities have nurtured his innovative spirit and supported his development of cutting-edge therapeutic compounds.

Collaborations

Throughout his career, Latacz has collaborated with talented professionals, including Krzysztof Kaminski and Michal Abram. These partnerships have contributed to the advancement of his research and innovation, enhancing the overall impact of his work in the field of medical treatments.

Conclusion

Gniewomir Latacz is an important figure in the realm of medical innovation. Through his patents, he is paving the way for new therapeutic options for patients grappling with neurological disorders and psychiatric issues. His dedication to research and collaboration highlights the vital role inventors play in improving healthcare outcomes and driving progress in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…